Stanley T Crooke - Net Worth and Insider Trading
Stanley T Crooke Net Worth
The estimated net worth of Stanley T Crooke is at least $21 Million dollars as of 2024-04-25. Stanley T Crooke is the Exec Chairman of the Board of Ionis Pharmaceuticals Inc and owns about 499,523 shares of Ionis Pharmaceuticals Inc (IONS) stock worth over $21 Million. Stanley T Crooke is also the Director, 10% Owner of Regulus Therapeutics Inc and owns about 58,746 shares of Regulus Therapeutics Inc (RGLS) stock worth over $130,416. Details can be seen in Stanley T Crooke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stanley T Crooke has not made any transactions after 2021-01-26 and currently still holds the listed stock(s).
Transaction Summary of Stanley T Crooke
Stanley T Crooke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stanley T Crooke owns 3 companies in total, including Ionis Pharmaceuticals Inc (IONS) , Akcea Therapeutics Inc (AKCA) , and Regulus Therapeutics Inc (RGLS) .
Click here to see the complete history of Stanley T Crooke’s form 4 insider trades.
Insider Ownership Summary of Stanley T Crooke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2021-01-26 | director & Chairman & President & CEO |
| AKCA | Akcea Therapeutics Inc | 2017-07-13 | director |
| RGLS | Regulus Therapeutics Inc | 2012-10-10 | director & 10 percent owner |
Stanley T Crooke Latest Holdings Summary
Stanley T Crooke currently owns a total of 2 stocks. Among these stocks, Stanley T Crooke owns 499,523 shares of Ionis Pharmaceuticals Inc (IONS) as of January 26, 2021, with a value of $21 Million and a weighting of 99.39%. Stanley T Crooke also owns 58,746 shares of Regulus Therapeutics Inc (RGLS) as of October 10, 2012, with a value of $130,416 and a weighting of 0.61%.
Latest Holdings of Stanley T Crooke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2021-01-26 | 499,523 | 42.45 | 21,204,751 |
| RGLS | Regulus Therapeutics Inc | 2012-10-10 | 58,746 | 2.22 | 130,416 |
Holding Weightings of Stanley T Crooke
Stanley T Crooke Form 4 Trading Tracker
According to the SEC Form 4 filings, Stanley T Crooke has made a total of 15 transactions in Ionis Pharmaceuticals Inc (IONS) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Ionis Pharmaceuticals Inc is the sale of 28,333 shares on January 26, 2021, which brought Stanley T Crooke around $2 Million.
According to the SEC Form 4 filings, Stanley T Crooke has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the acquisition of 6,250 shares on October 10, 2012, which cost Stanley T Crooke around $3 Million.
Insider Trading History of Stanley T Crooke
- 1
Stanley T Crooke Trading Performance
GuruFocus tracks the stock performance after each of Stanley T Crooke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stanley T Crooke is 36.87%. GuruFocus also compares Stanley T Crooke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stanley T Crooke within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stanley T Crooke's insider trading performs compared to the benchmark.
Performance of Stanley T Crooke
Average Return
116.63%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.31 | 36.87 | 63.37 | 116.63 | 23.6 | 18.26 |
| Relative Return to S&P 500(%) | 21.99 | 34.11 | 52.54 | 98.48 | 8.25 | 6.21 |
Stanley T Crooke Ownership Network
Ownership Network List of Stanley T Crooke
Ownership Network Relation of Stanley T Crooke
Stanley T Crooke Owned Company Details
What does Ionis Pharmaceuticals Inc do?
Who are the key executives at Ionis Pharmaceuticals Inc?
Stanley T Crooke is the director & Chairman & President & CEO of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include EVP & Corp and Development Ops Brian Birchler , Chief Business Officer Joseph Baroldi , and director & Senior Vice President Brett P Monia .
Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary
Over the past 18 months, Stanley T Crooke made no insider transaction in Ionis Pharmaceuticals Inc (IONS). Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 183,300 shares made by Brett P Monia , a net sale of 57,263 shares made by Patrick R. O'neil , and a net sale of 67,074 shares made by C Frank Bennett .
In summary, during the past 3 months, insiders sold 53,575 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 53,575 shares. During the past 18 months, 639,101 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639,101 shares.
Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ionis Pharmaceuticals Inc Insider Transactions
Stanley T Crooke Mailing Address
Above is the net worth, insider trading, and ownership report for Stanley T Crooke. You might contact Stanley T Crooke via mailing address: 2855 Gazelle Court, Carlsbad Ca 92010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
